Provided by Tiger Trade Technology Pte. Ltd.

Tscan Therapeutics, Inc.

1.16
+0.01000.87%
Post-market: 1.170.0100+0.86%16:10 EDT
Volume:438.79K
Turnover:513.42K
Market Cap:69.72M
PE:-1.16
High:1.20
Open:1.15
Low:1.13
Close:1.15
52wk High:2.57
52wk Low:0.8824
Shares:60.10M
Float Shares:44.03M
Volume Ratio:0.51
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0000
EPS(LYR):-1.0000
ROE:-71.28%
ROA:-27.88%
PB:0.57
PE(LYR):-1.16

Loading ...

Company Profile

Company Name:
Tscan Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
142
Office Location:
830 Winter Street,Waltham,Massachusetts,United States
Zip Code:
02451
Fax:
- -
Introduction:
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 that is in Phase I clinical trial for the treatment of patients with hematologic malignancies to eliminate residual disease and prevent relapse after allogeneic hematopoietic cell transplantation. It also develops TSC-200, TSC-201, TSC-203, and TSC-204, which are in Phase 1 clinical trial, for the treatment of solid tumors; and TSC-202 to treat solid tumors. In addition, the company develops vaccines for infectious diseases, such as SARS-CoV-2. It has collaborations with Novartis Institutes for BioMedical Research, Inc. To discover and develop novel TCR-T therapies; and Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease using TargetScan, a proprietary target discovery platform. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Directors

Name
Position
Gavin MacBeath
Chief Executive Officer and Director
Barbara Klencke
Independent Director
Gabriela Gruia
Independent Director
Garry Nicholson
Independent Director
Katina Dorton
Independent Director
R. Keith Woods
Independent Director
Stephen Biggar
Chair of the Board and Independent Director

Shareholders

Name
Position
Gavin MacBeath
Chief Executive Officer and Director
Jason A. Amello
Chief Financial Officer and Treasurer
Chrystal Louis
Chief Medical Officer
Zoran Zdraveski
Chief Legal and Strategy Officer and Secretary